Creating a wearable device to detect opioid overdoses
Developing a wearable medical device to detect opioid overdose
This study is testing a new wearable device that helps keep people safe from opioid overdoses by monitoring their breathing and sending alerts to loved ones or emergency services if there's a problem, making it a helpful tool for anyone at risk.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Resilient Lifescience, INC. NIH-funded |
| Lab location | 1 site (Pittsburgh, UNITED STATES) |
| Project ID | NIH-11268256 on NIH RePORTER |
What this research studies
This research focuses on developing a wearable medical device that can continuously monitor individuals at risk of opioid overdose. The device aims to detect signs of Opioid Induced Respiratory Depression (OIRD) and send emergency alerts to friends, family, or emergency services when an overdose is detected. By addressing the critical issue of overdose deaths occurring without bystanders present, this technology seeks to improve response times and save lives. The project also involves validating the business model for marketing this device to families and healthcare providers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Opioid Use Disorder (OUD) who are at risk of overdose.
Not a fit: Patients who do not have Opioid Use Disorder or are not at risk of opioid overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the number of fatal opioid overdoses by enabling timely intervention.
How similar studies have performed: While wearable devices for health monitoring are becoming more common, this specific approach to detecting opioid overdose is novel and has not been widely tested.
Where this research is happening
Pittsburgh, UNITED STATES
- Resilient Lifescience, INC. — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Holden, Bradford a — Resilient Lifescience, INC.
- Study coordinator: Holden, Bradford a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.